CDH1 and breast carcinoma: In our experiments, the enhanced E-cadherin expression as well as the reduced expression of Snail, Vimentin, and N-cadherin also suggested that knockdown of ABRACL inhibited the EMT process in breast cancer cells, which was in line with the above study.